Acta Neuropathologica

, Volume 115, Issue 3, pp 335–343 | Cite as

Dexamethasone suppresses infiltration of RhoA+ cells into early lesions of rat traumatic brain injury

  • Zhiren Zhang
  • Uwe Fauser
  • Hermann J. Schluesener
Original Paper
First Online:
Received:
Revised:
Accepted:

Abstract

Inflammatory cell infiltration is a major part of secondary tissue damage in traumatic brain injury (TBI). RhoA is an important member of Rho GTPases and is involved in leukocyte migration. Inhibition of RhoA and its downstream target, Rho-associated coiled kinase (ROCK), has been proven to promote axon regeneration and function recovery following injury in the central nervous system (CNS). Previously, we showed that dexamethasone, an immunosuppressive corticosteroid, attenuated early expression of three molecules associated with microglia/macrophages activation following TBI in rats. Here, the effects of dexamethasone on the early expression of RhoA have been investigated in brains of TBI rats by immunohistochemistry. In brains of rats treated with TBI alone, significant RhoA+ cell accumulation was observed at 18 h post-injury and continuously increased during our observed time period. The accumulated RhoA+ cells were distributed to the areas of pannecrosis and selective neuronal loss. Most accumulated RhoA+ cells were identified as active microglia/macrophages by double-labelling. Dexamethasone (1 mg/kg body weight) was intraperitoneally injected on day 0 and 2 immediately following brain injury. Numbers of RhoA+ cells were significantly reduced on day 1 and 2 following administration of dexamethasone but returned to vehicle control level on day 4. However, dexamethasone treatment did not change the proportion of RhoA+ cells. These observations suggest that dexamethasone has only a transient effect on early leukocyte recruitment.

Keywords

RhoA Dexamethasone Traumatic brain injury Microglia Macrophages Weight-drop model 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This work has been supported by the BMBF (03134298). The authors are solely responsible for the content of this article.

References

  1. 1.
    Alblas J, Ulfman L, Hordijk P, Koenderman L (2001) Activation of RhoA and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 12:2137–2145PubMedGoogle Scholar
  2. 2.
    Angkachatchai V, Finkel TH (1999) ADP-ribosylation of rho by C3 ribosyltransferase inhibits IL-2 production and sustained calcium influx in activated T cells. J Immunol 163:3819–3825PubMedGoogle Scholar
  3. 3.
    Barks JD, Post M, Tuor UI (1991) Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 29:558–563PubMedCrossRefGoogle Scholar
  4. 4.
    Brabeck C, Beschorner R, Conrad S, Mittelbronn M, Bekure K, Meyermann R, Schluesener HJ, Schwab JM (2004) Lesional expression of RhoA and RhoB following traumatic brain injury in humans. J Neurotrauma 21:697–706PubMedCrossRefGoogle Scholar
  5. 5.
    Chardin P, Boquet P, Madaule P, Popoff MR, Rubin EJ, Gill DM (1989) The mammalian G protein RhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J 8:1087–1092PubMedGoogle Scholar
  6. 6.
    Conrad S, Schluesener HJ, Trautmann K, Joannin N, Meyermann R, Schwab JM (2005) Prolonged lesional expression of RhoA and RhoB following spinal cord injury. J Comp Neurol 487:166–175PubMedCrossRefGoogle Scholar
  7. 7.
    Cooper PR, Moody S, Clark WK, Kirkpatrick J, Maravilla K, Gould AL, Drane W (1979) Dexamethasone and severe head injury. A prospective double-blind study. J Neurosurg 51:307–316PubMedGoogle Scholar
  8. 8.
    Dearden NM, Gibson JS, McDowall DG, Gibson RM, Cameron MM (1986) Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg 64:81–88PubMedGoogle Scholar
  9. 9.
    Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, McKerracher L (2002) Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22:6570–6577PubMedGoogle Scholar
  10. 10.
    Donovan FM, Pike CJ, Cotman CW, Cunningham DD (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316–5326PubMedGoogle Scholar
  11. 11.
    Dubreuil CI, Winton MJ, McKerracher L (2003) Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol 162:233–243PubMedCrossRefGoogle Scholar
  12. 12.
    Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420:629–635PubMedCrossRefGoogle Scholar
  13. 13.
    Eto M, Kozai T, Cosentino F, Joch H, Luscher TF (2002) Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 105:1756–1759PubMedCrossRefGoogle Scholar
  14. 14.
    Felszeghy K, Banisadr G, Rostene W, Nyakas C, Haour F (2004) Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 11:404–413PubMedCrossRefGoogle Scholar
  15. 15.
    Fournier AE, Takizawa BT, Strittmatter SM (2003) Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 23:1416–1423PubMedGoogle Scholar
  16. 16.
    Gaab MR, Trost HA, Alcantara A, Karimi-Nejad A, Moskopp D, Schultheiss R, Bock WJ, Piek J, Klinge H, Scheil F (1994) “Ultrahigh” dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German ultrahigh dexamethasone head injury study group. Zentralbl Neurochir 55:135–143PubMedGoogle Scholar
  17. 17.
    Gahm C, Holmin S, Rudehill S, Mathiesen T (2005) Neuronal degeneration and iNOS expression in experimental brain contusion following treatment with colchicine, dexamethasone, tirilazad mesylate and nimodipine. Acta Neurochir (Wien) 147:1071–1084CrossRefGoogle Scholar
  18. 18.
    Gottesfeld Z, Moore AN, Dash PK (2002) Acute ethanol intake attenuates inflammatory cytokines after brain injury in rats: a possible role for corticosterone. J Neurotrauma 19:317–326PubMedCrossRefGoogle Scholar
  19. 19.
    Graham DI, McIntosh TK, Maxwell WL, Nicoll JA (2000) Recent advances in neurotrauma. J Neuropathol Exp Neurol 59:641–651PubMedGoogle Scholar
  20. 20.
    Greenwood J, Walters CE, Pryce G, Kanuga N, Beraud E, Baker D, Adamson P (2003) Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis. FASEB J 17:905–907PubMedGoogle Scholar
  21. 21.
    Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509–514PubMedCrossRefGoogle Scholar
  22. 22.
    Hall ED, McCall JM, Chase RL, Yonkers PA, Braughler JM (1987) A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp Ther 242:137–142PubMedGoogle Scholar
  23. 23.
    Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE (2004) Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 200:1667–1672PubMedCrossRefGoogle Scholar
  24. 24.
    Holmin S, Mathiesen T (1996) Dexamethasone and colchicine reduce inflammation and delayed oedema following experimental brain contusion. Acta Neurochir (Wien) 138:418–424CrossRefGoogle Scholar
  25. 25.
    Irazuzta J, Pretzlaff RK, DeCourten-Myers G, Zemlan F, Zingarelli B (2005) Dexamethasone decreases neurological sequelae and caspase activity. Intensive Care Med 31:146–150PubMedCrossRefGoogle Scholar
  26. 26.
    Kim JS, Kim JG, Jeon CY, Won HY, Moon MY, Seo JY, Kim JI, Kim J, Lee JY, Choi SY, Park J, Yoon Park JH, Ha KS, Kim PH, Park JB (2005) Downstream components of RhoA required for signal pathway of superoxide formation during phagocytosis of serum opsonized zymosans in macrophages. Exp Mol Med 37:575–587PubMedGoogle Scholar
  27. 27.
    Knaus UG (2000) Rho GTPase signaling in inflammation and transformation. Immunol Res 21:103–109PubMedCrossRefGoogle Scholar
  28. 28.
    Kubes P, Ward PA (2000) Leukocyte recruitment and the acute inflammatory response. Brain Pathol 10:127–135PubMedCrossRefGoogle Scholar
  29. 29.
    Lang P, Guizani L, Vitte-Mony I, Stancou R, Dorseuil O, Gacon G, Bertoglio J (1992) ADP-ribosylation of the ras-related, GTP-binding protein RhoA inhibits lymphocyte-mediated cytotoxicity. J Biol Chem 267:11677–11680PubMedGoogle Scholar
  30. 30.
    Luo L (2000) Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1:173–180PubMedCrossRefGoogle Scholar
  31. 31.
    Maderna P, Cottell DC, Berlasconi G, Petasis NA, Brady HR, Godson C (2002) Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. Am J Pathol 160:2275–2283PubMedGoogle Scholar
  32. 32.
    Marshall LF (2000) Head injury: recent past, present, and future. Neurosurgery 47:546–561PubMedCrossRefGoogle Scholar
  33. 33.
    Muller CA, Schluesener HJ, Conrad S, Myermann R, Schwab JM (2003) Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endothelium and microglia/macrophages during secondary damage following experimental traumatic brain injury. J Neuroimmunol 135:1–9CrossRefGoogle Scholar
  34. 34.
    Mueller BK, Mack H, Teusch N (2005) Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 4:387–398PubMedCrossRefGoogle Scholar
  35. 35.
    Negishi M, Katoh H (2002) Rho family GTPases as key regulators for neuronal network formation. J Biochem (Tokyo) 132:157–166Google Scholar
  36. 36.
    O’Connor KL, Nguyen BK, Mercurio AM (2000) RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J Cell Biol 148:253–258PubMedCrossRefGoogle Scholar
  37. 37.
    O’Kane EM, Stone TW, Morris BJ (2003) Distribution of Rho family GTPases in the adult rat hippocampus and cerebellum. Brain Res Mol Brain Res 114:1–8PubMedCrossRefGoogle Scholar
  38. 38.
    Pertz O, Hodgson L, Klemke RL, Hahn KM (2006) Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 440:1069–1072PubMedCrossRefGoogle Scholar
  39. 39.
    Pixley FJ, Xiong Y, Yu RY, Sahai EA, Stanley ER, Ye BH (2005) BCL6 suppresses RhoA activity to alter macrophage morphology and motility. J Cell Sci 118:1873–1883PubMedCrossRefGoogle Scholar
  40. 40.
    Ridley AJ (2001) Rho GTPases and cell migration. J Cell Sci 114:2713–2722PubMedGoogle Scholar
  41. 41.
    Ridley AJ (2001) Rho family proteins: coordinating cell responses. Trends Cell Biol 11:471–477PubMedCrossRefGoogle Scholar
  42. 42.
    Ridley AJ (2001) Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Lett 498:168–171PubMedCrossRefGoogle Scholar
  43. 43.
    Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloe V, Munoz-Sanchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P, CRASH trial collaborators (2004) Effect of intravenous corticosteroids on death within 14 days in 10,008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364:1321–1328PubMedCrossRefGoogle Scholar
  44. 44.
    Rubin EJ, Gill DM, Boquet P, Popoff MR (1988) Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum. Mol Cell Biol 8:418–426PubMedGoogle Scholar
  45. 45.
    Sandvig A, Berry M, Barrett LB, Butt A, Logan A (2004) Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46:225–251PubMedCrossRefGoogle Scholar
  46. 46.
    Sauerland S, Maegele M (2004) A CRASH landing in severe head injury. Lancet 364:1291–1292PubMedCrossRefGoogle Scholar
  47. 47.
    Schluesener HJ, Seid K, Zhao Y, Meyermann R (1997) Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells. Glia 20:365–372PubMedCrossRefGoogle Scholar
  48. 48.
    Schwab ME (2004) Nogo and axon regeneration. Curr Opin Neurobiol 14:118–124PubMedCrossRefGoogle Scholar
  49. 49.
    Skaper SD, Moore SE, Walsh FS (2001) Cell signalling cascades regulating neuronal growth-promoting and inhibitory cues. Prog Neurobiol 65:593–608PubMedCrossRefGoogle Scholar
  50. 50.
    Stramer B, Wood W, Galko MJ, Redd MJ, Jacinto A, Parkhurst SM, Martin P (2005) Live imaging of wound inflammation in Drosophila embryos reveals key roles for small GTPases during in vivo cell migration. J Cell Biol 168:567–573PubMedCrossRefGoogle Scholar
  51. 51.
    Tapon N, Hall A (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9:86–92PubMedCrossRefGoogle Scholar
  52. 52.
    Walters CE, Pryce G, Hankey DJ, Sebti SM, Hamilton AD, Baker D, Greenwood J, Adamson P (2002) Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis. J Immunol 168:4087–4094PubMedGoogle Scholar
  53. 53.
    Wheeler AP, Ridley AJ (2004) Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301:43–49PubMedCrossRefGoogle Scholar
  54. 54.
    Yang JT, Lee TH, Weng HH, Chang CN, Chen WC, Cheng WC, Wu JH (2005) Dexamethasone enhances NT-3 expression in rat hippocampus after traumatic brain injury. Exp Neurol 192:437–443PubMedCrossRefGoogle Scholar
  55. 55.
    Zhang Z, Artelt M, Burnet M, Trautmann K, Schluesener HJ (2006) Lesional accumulation of P2X4 receptor+ monocytes following experimental traumatic brain injury. Exp Neurol 197:252–257PubMedCrossRefGoogle Scholar
  56. 56.
    Zhang Z, Zhang Z, Artelt M, Burnet M, Schluesener HJ (2007) Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury. Acta Neuropathol 113:675–682PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Zhiren Zhang
    • 1
  • Uwe Fauser
    • 1
  • Hermann J. Schluesener
    • 1
  1. 1.Institute of Brain ResearchUniversity of TuebingenTuebingenGermany

Personalised recommendations